|
ILF3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.039960E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.562400E-03 |
| Normal-vs-Stage2 |
2.563900E-02 |
| Normal-vs-Stage3 |
1.060580E-03 |
| Normal-vs-Stage4 |
2.246400E-02 |
| Stage1-vs-Stage2 |
5.853800E-01 |
| Stage1-vs-Stage3 |
2.713400E-01 |
| Stage1-vs-Stage4 |
8.273200E-01 |
| Stage2-vs-Stage3 |
8.230000E-01 |
| Stage2-vs-Stage4 |
7.921000E-01 |
| Stage3-vs-Stage4 |
5.710600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.322180E-03 |
| Normal-vs-AfricanAmerican |
8.008800E-01 |
| Normal-vs-Asian |
1.513230E-01 |
| Caucasian-vs-AfricanAmerican |
1.027980E-01 |
| Caucasian-vs-Asian |
2.842200E-01 |
| AfricanAmerican-vs-Asian |
4.035200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.360260E-02 |
| Normal-vs-Female |
8.751600E-04 |
| Male-vs-Female |
5.237000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.721300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.262500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.305000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.165380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.239600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.272000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.862800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.249400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.641400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.687200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.80934999999272E-05 |
| Classical-VS-Follicular |
6.23979999999635E-05 |
| Classical-VS-Other |
6.788600E-01 |
| Classical-VS-Normal |
1.651610E-01 |
| Tall-VS-Follicular |
2.795200E-01 |
| Tall-VS-Other |
1.068170E-01 |
| Tall-VS-Normal |
1.68889999996313E-06 |
| Follicular-VS-Other |
4.079600E-01 |
| Follicular-VS-Normal |
4.15099999999669E-05 |
| Other-VS-Normal |
2.927800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.824720E-03 |
| Normal-vs-N1 |
1.425610E-02 |
| N0-vs-N1 |
9.309600E-01 |
|
|
